Learn more

TOA EIYO LTD

Overview
  • Total Patents
    186
  • GoodIP Patent Rank
    34,819
  • Filing trend
    ⇩ 66.0%
About

TOA EIYO LTD has a total of 186 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 1982. It filed its patents most often in Japan, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are HAESSLE AB, LEAD PHARMA HOLDING BV and SMITHKLINE BEECHAMP P L C.

Patent filings per year

Chart showing TOA EIYO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Uemoto Kazuhiro 29
#2 Masaki Hidekazu 26
#3 Kageyama Masayuki 24
#4 Hasegawa Takeshi 20
#5 Narita Senichi 17
#6 Kojo Kentaro 16
#7 Okada Naoki 15
#8 Takayanagi Koichi 15
#9 Yamada Shinichi 15
#10 Takahashi Atsuo 15

Latest patents

Publication Filing date Title
JP2020180059A Vasopressin receptor antagonist
WO2019082910A1 Vasopressin receptor antagonist
JP2019019125A Orally disintegrating tablet and method for producing the same
JP2019202965A Serotonin receptor antagonist-containing percutaneous absorption preparation
JP2018076303A Acute heart failure therapeutic agent
US2019231724A1 Therapeutic agent for glaucoma
JP2019006682A Orally disintegrating tablet
JP2018177758A Rivastigmine-containing percutaneously absorbable pharmaceutical preparation
CA2989397A1 Adhesive preparation containing bisoprolol
JP2017128528A Method for producing (s)-2-hydroxypropanoic acid derivative
US2017190699A1 Substituted tropane derivatives
US2017050919A1 Cyclic hydrocarbon compound
CN105658621A 4-aminomethylbenzoic acid derivative
JP2017036215A Salt of angiotensin ii receptor antagonistic substance
JP2015124213A Percutaneous administration preparation
US2015119418A1 Bicyclic compound
JP2014180234A Acute cardiac failure model, method for evaluating acute cardiac failure therapeutic medicine using the same, and method for making acute cardiac failure model
EP2578573A1 Fused imidazole derivative
JP2012012063A Packing box
JP2012001447A Etilefrine percutaneous absorbent